Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Jul 12 2024
Business
Jul 12 2024
4 min read

Press Release Jul 12 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 12, 2024, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval Selexipag for Injection, 1,800 mcg/vial".

View Attachment